"One of the great things about coming to KC is it is it is such a great family and community-based environment, there is a great tradition of philanthropic support for Children’s Mercy. For research, that is critical. When you study a rare pediatric disease, you have trouble getting grants. Because the number of patients involved is small. When you argue the impact on patients and families is enormous, that doesn’t cut it when it comes to the competitive grant process. So it’s essential to fund the initial research process with philanthropic dollars. I call those golden dollars because it allows us to work on the most important opportunities for our kids." - Dr. Curran
We know the way a disease expresses itself in a child is different from an adult, different between children and different at each stage of a child’s development. [From our smallest patients to young adults, each stage of a child’s development requires its own health care expertise, equipment and understanding.]
Despite this fact, children, particularly those with rare diseases, have been a neglected population in medical research. In fact, the National Institutes of Health dedicates only about 5 percent of its annual extramural research budget to pediatric research.
Children should not have to wait for life-changing treatments.
As a leading pediatric teaching hospital, Children’s Mercy is at a unique advantage to change the current research paradigm and improve the future for children … now!
Data from ongoing surveys by the National Science Foundation (NSF) show that federal agencies provided only 44 percent of the $86 billion spent on basic research in 2015. The federal share, which topped 70 percent throughout the 1960s and 70s, stood at 61 percent as recently as 2004 before falling below 50 percent in 2013.